{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:46:46Z","timestamp":1790063206045,"version":"4.0.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Atypical progeroid syndrome (APS) is a rare type of progeroid syndrome mainly caused by heterozygous missense mutations in the <jats:italic>LMNA<\/jats:italic> (MIM 150330) gene. APS has heterogeneous clinical manifestations, and its kidney manifestations, particularly in children, are rarely documented. Here, we report the first pediatric case of APS with focal segmental glomerulosclerosis (FSGS). A 10-year-old boy with progeroid features was referred to the nephrology clinic because of hyperuricemia. He had dark skin, protruding eyes, and beaked nose and was very thin, suggesting lipodystrophy. He had been treated for recurrent urinary tract infection during infancy, and liver biopsy for persisting hepatitis showed steatohepatitis. He also had hypertrophic cardiomyopathy (HCMP) with mitral and tricuspid valve regurgitation. Genetic studies were performed considering his multisystem symptoms, and he was diagnosed as having APS according to exome sequencing findings (c.898G\u2009&amp;gt;\u2009C, <jats:italic>p<\/jats:italic>.Asp300His of <jats:italic>LMNA<\/jats:italic>). During the first visit to the nephrology clinic, he had minimal proteinuria (urine protein\/creatinine ratio of 0.23\u2005mg\/mg), which worsened during follow-up. In three years, his urine protein\/creatinine ratio and N-acetyl-b-D-glucosaminidase\/creatinine ratio increased to 1.52 and 18.7, respectively. The kidney biopsy result was consistent with findings of FSGS, peri-hilar type, showing segmental sclerosis of 1 (5%) glomerulus out of 21 glomeruli. An angiotensin receptor blocker was added to manage his proteinuria. This is the first pediatric report of FSGS in an APS patient with confirmed <jats:italic>LMNA<\/jats:italic> defect, who manifested progeroid features, lipodystrophy, HCMP with heart valve dysfunction, and steatohepatitis. Our case suggests that screening for proteinuric nephropathy is essential for managing APS patients since childhood.<\/jats:p>","DOI":"10.3389\/fped.2022.1032653","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T07:11:08Z","timestamp":1667200268000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case report: Focal segmental glomerulosclerosis in a pediatric atypical progeroid syndrome"],"prefix":"10.3389","volume":"10","author":[{"given":"Seoyun","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo Han","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Min","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Sung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sojung","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Gyung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1242\/dmm.024711","article-title":"Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells","volume":"9","author":"Carrero","year":"2016","journal-title":"Dis Model Mech"},{"key":"B2","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1093\/hmg\/ddl214","article-title":"Molecular bases of progeroid syndromes","volume":"15","author":"Navarro","year":"2006","journal-title":"Hum Mol Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1083\/jcb.70.3.581","article-title":"A modified procedure for the isolation of a pore complex-lamina fraction from rat liver nuclei","volume":"70","author":"Dwyer","year":"1976","journal-title":"J Cell Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jsb.2011.11.007","article-title":"Nuclear lamina at the crossroads of the cytoplasm and nucleus","volume":"177","author":"Gerace","year":"2012","journal-title":"J Struct Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrm3488","article-title":"The nuclear lamins: flexibility in function","volume":"14","author":"Burke","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/ncb1792","article-title":"Tethering by lamin A stabilizes and targets the ING1 tumour suppressor","volume":"10","author":"Han","year":"2008","journal-title":"Nat Cell Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1101\/gad.349506","article-title":"A mechanism of AP-1 suppression through interaction of c-Fos with lamin A\/C","volume":"20","author":"Ivorra","year":"2006","journal-title":"Genes Dev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"a000554","DOI":"10.1101\/cshperspect.a000554","article-title":"Lamin-binding proteins","volume":"2","author":"Wilson","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"a000760","DOI":"10.1101\/cshperspect.a000760","article-title":"Diseases of the nuclear envelope","volume":"2","author":"Worman","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.yexcr.2007.03.028","article-title":"\u201cLaminopathies\u201d: a wide spectrum of human diseases","volume":"313","author":"Worman","year":"2007","journal-title":"Exp Cell Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/19491034.2018.1454167","article-title":"Lipodystrophic laminopathies diagn clues","volume":"9","author":"Fernandez-Pombo","year":"2018","journal-title":"Nucleus"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1002\/ajmg.a.31346","article-title":"Hutchinson-Gilford progeria syndrome: review of the phenotype","volume":"140","author":"Hennekam","year":"2006","journal-title":"Am J Med Genet A"},{"key":"B13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1056\/NEJMoa0706898","article-title":"Phenotype and course of Hutchinson-Gilford progeria syndrome","volume":"358","author":"Merideth","year":"2008","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1002\/ajmg.a.35557","article-title":"An inherited LMNA gene mutation in atypical progeria syndrome","author":"Doubaj","year":"2012","journal-title":"Am J Med Genet A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1210\/jc.2009-0472","article-title":"Atypical progeroid syndrome due to heterozygous missense LMNA mutations","volume":"94","author":"Garg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1126\/science.1084125","article-title":"Lamin a truncation in Hutchinson-Gilford progeria","volume":"300","author":"De Sandre-Giovannoli","year":"2003","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1073\/pnas.0700854104","article-title":"Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging","volume":"104","author":"Dechat","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/hmg\/ddl026","article-title":"The truncated prelamin A in Hutchinson-Gilford progeria syndrome alters segregation of A-type and B-type lamin homopolymers","volume":"15","author":"Delbarre","year":"2006","journal-title":"Hum Mol Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1242\/jcs.03263","article-title":"DNA Damage responses in progeroid syndromes arise from defective maturation of prelamin A","volume":"119","author":"Liu","year":"2006","journal-title":"J Cell Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8703","DOI":"10.1073\/pnas.0602569103","article-title":"Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging","volume":"103","author":"Shumaker","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/cen.13311","article-title":"Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort","volume":"86","author":"Ajluni","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"bvaa104","DOI":"10.1210\/jendso\/bvaa104","article-title":"Multisystem progeroid syndrome with lipodystrophy, cardiomyopathy, and nephropathy due to an LMNA p.R349W variant","volume":"4","author":"Hussain","year":"2020","journal-title":"J Endocr Soc"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1210\/jc.2017-02078","article-title":"A novel generalized lipodystrophy-associated progeroid syndrome due to recurrent heterozygous LMNA p.T10I mutation","volume":"103","author":"Hussain","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.31491\/apt.2020.06.021","article-title":"Novel LMNA mutations in Greek and Myanmar patients with progeroid features and cardiac manifestations","volume":"2","author":"Kandhaya-Pillai","year":"2020","journal-title":"Aging Pathobiol Ther"},{"key":"B26","doi-asserted-by":"publisher","first-page":"bvaa108","DOI":"10.1210\/jendso\/bvaa108","article-title":"Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation","volume":"4","author":"Magno","year":"2020","journal-title":"J Endocr Soc"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/1346-8138.12657","article-title":"First Japanese case of atypical progeroid syndrome\/atypical Werner syndrome with heterozygous LMNA mutation","volume":"41","author":"Motegi","year":"2014","journal-title":"J Dermatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1161\/STROKEAHA.108.531780","article-title":"Novel LMNA mutation in atypical werner syndrome presenting with ischemic disease","volume":"40","author":"Renard","year":"2009","journal-title":"Stroke"},{"key":"B29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3389\/fendo.2018.00433","article-title":"Cerebral haemorrhage in a young patient with atypical Werner syndrome due to mutations in LMNA","volume":"9","author":"Yanhua","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00223-019-00639-5","article-title":"Recurrent femoral fractures in a boy with an atypical progeroid syndrome: a case report","volume":"106","author":"Jiajue","year":"2020","journal-title":"Calcif Tissue Int"},{"key":"B31","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/pde.13917","article-title":"Diffuse, mottled hyperpigmentation and mutations in LMNA gene in a 5-year-old boy, his mother, and his grandmother: atypical progeroid syndrome","volume":"36","author":"Schultz","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"20-0188","DOI":"10.1530\/EDM-20-0188","article-title":"Atypical progeroid syndrome (p.E262K LMNA mutation): a rare cause of short stature and osteoporosis","volume":"2021","author":"Yukina","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/1346-8138.13005","article-title":"Genomic diagnosis by whole genome sequencing in a Korean family with atypical progeroid syndrome","volume":"42","author":"Lee","year":"2015","journal-title":"J Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/j.1651-2227.2009.01324.x","article-title":"Homozygous LMNA mutation R527C in atypical Hutchinson-Gilford progeria syndrome: evidence for autosomal recessive inheritance","volume":"98","author":"Liang","year":"2009","journal-title":"Acta Paediatr"},{"key":"B35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3904\/kjim.2009.24.1.68","article-title":"Novel LMNA gene mutation in a patient with atypical Werner's Syndrome","volume":"24","author":"Doh","year":"2009","journal-title":"Korean J Intern Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e00375","DOI":"10.14309\/crj.0000000000000375","article-title":"Hepatic steatosis resulting from LMNA-associated familial lipodystrophy","volume":"7","author":"Mahdi","year":"2020","journal-title":"ACG Case Rep J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"17-0049","DOI":"10.1530\/EDM-17-0049","article-title":"Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C > T LMNA mutation","volume":"2017","author":"Fountas","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12020-008-9127-1","article-title":"A case of Dunnigan-type familial partial lipodystrophy (FPLD) due to lamin A\/C (LMNA) mutations complicated by end-stage renal disease","volume":"35","author":"Imachi","year":"2009","journal-title":"Endocrine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"c35","DOI":"10.1159\/000076396","article-title":"Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome)","volume":"96","author":"Owen","year":"2004","journal-title":"Nephron Clin Pract"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/ajmg.a.32331","article-title":"Extreme phenotypic diversity and nonpenetrance in families with the LMNA gene mutation R644C","author":"Rankin","year":"2008","journal-title":"Am J Med Genet A"},{"key":"B41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000354716","article-title":"Cosegregation of focal segmental glomerulosclerosis in a family with familial partial lipodystrophy due to a mutation in LMNA","volume":"124","author":"Thong","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1172\/JCI119815","article-title":"Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice","volume":"100","author":"Clouthier","year":"1997","journal-title":"J Clin Invest"},{"key":"B43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1194\/jlr.M071381","article-title":"Extracellular matrix remodeling and transforming growth factor-beta signaling abnormalities induced by lamin A\/C variants that cause lipodystrophy","volume":"58","author":"Le Dour","year":"2017","journal-title":"J Lipid Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-beta in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3339\/ckd.22.020","article-title":"Mechanism, clinical consequences, and management of dyslipidemia in children with nephrotic syndrome","volume":"26","author":"Baek","year":"2022","journal-title":"Child Kidney Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1046\/j.1523-1755.2003.00288.x","article-title":"Activation of the TGF-beta\/smad signaling pathway in focal segmental glomerulosclerosis","volume":"64","author":"Kim","year":"2003","journal-title":"Kidney Int"},{"key":"B47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000285844","article-title":"Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies","volume":"33","author":"Lee","year":"2010","journal-title":"Kidney Blood Press Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1093\/hmg\/ddi316","article-title":"A-type lamins are essential for TGF-beta1 induced PP2A to dephosphorylate transcription factors","volume":"14","author":"Van Berlo","year":"2005","journal-title":"Hum Mol Genet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12882-018-0913-6","article-title":"The renal manifestations of type 4 familial partial lipodystrophy: a case report and review of literature","volume":"19","author":"Chen","year":"2018","journal-title":"BMC Nephrol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"F12","DOI":"10.1152\/ajprenal.00399.2018","article-title":"Early podocyte injury and elevated levels of urinary podocyte-derived extracellular vesicles in swine with metabolic syndrome: role of podocyte mitochondria","volume":"317","author":"Zhang","year":"2019","journal-title":"Am J Physiol Ren Physiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.krcp.2011.12.001","article-title":"Smads as therapeutic targets for chronic kidney disease","volume":"31","author":"Lan","year":"2012","journal-title":"Kidney Res Clin Pract"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ki.2011.33","article-title":"A phase 1, single-dose study of fresolimumab, an anti-TGF-beta antibody, in treatment-resistant primary focal segmental glomerulosclerosis","volume":"79","author":"Trachtman","year":"2011","journal-title":"Kidney Int"},{"key":"B53","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ekir.2017.03.011","article-title":"A phase 2, double-blind, placebo-controlled, randomized study of fresolimumab in patients with steroid-resistant primary focal segmental glomerulosclerosis","volume":"2","author":"Vincenti","year":"2017","journal-title":"Kidney Int Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/19491034.2018.1460045","article-title":"An overview of treatment strategies for Hutchinson-Gilford progeria syndrome","volume":"9","author":"Harhouri","year":"2018","journal-title":"Nucleus"},{"key":"B55","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nm1786","article-title":"Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging","volume":"14","author":"Varela","year":"2008","journal-title":"Nat Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"12873","DOI":"10.1073\/pnas.0505767102","article-title":"Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes","volume":"102","author":"Toth","year":"2005","journal-title":"Proc Natl Acad Sci"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1032653\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T07:11:11Z","timestamp":1667200271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1032653\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":56,"alternative-id":["10.3389\/fped.2022.1032653"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1032653","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"article-number":"1032653"}}